US Broker Ratings

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Eyeing a 45.94% Upside Potential in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline and significant upside potential. Specializing in the development and commercialization of..

Beta Bionics, Inc. (BBNX) Stock Analysis: Exploring a Potential 93% Upside in Medical Devices

Beta Bionics, Inc. (NASDAQ: BBNX) is capturing the attention of investors with its innovative approach in the healthcare sector, specifically within the medical devices industry. The company is at the..

Immatics N.V. (IMTX) Stock Analysis: Potential 68% Upside Amid Strategic Collaborations and Innovative Cancer Therapies

Immatics N.V. (NASDAQ: IMTX), a promising player in the biotechnology sector, is capturing investor attention with its cutting-edge approach to cancer treatment. Headquartered in Tübingen, Germany, this clinical-stage biopharmaceutical company..

Rocket Pharmaceuticals (RCKT) Investor Outlook: Exploring a 140.90% Potential Upside in Genetic Therapies

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a promising player in the biotechnology sector, leveraging cutting-edge genetic therapies aimed at treating rare and devastating diseases. With a current market capitalization of..

HealthStream, Inc. (HSTM) Stock Analysis: Unveiling a 35.94% Potential Upside in Health Information Services

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the health information services industry, presents an intriguing opportunity for investors looking for growth in the healthcare sector. With a market capitalization..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a 22% Potential Upside Amidst a Challenging Landscape

Fulgent Genetics, Inc. (NASDAQ: FLGT), a prominent player in the healthcare sector specializing in diagnostics and research, offers a mixed bag of opportunities and challenges for investors. Currently trading at..

AnaptysBio, Inc. (ANAB) Stock Analysis: Unpacking a 21.51% Upside Potential Amid Robust Revenue Growth

AnaptysBio, Inc. (NASDAQ: ANAB) is a clinical-stage biotechnology company that has caught the attention of investors with its focus on delivering cutting-edge immunology therapeutics for autoimmune and inflammatory diseases. With..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Exploring a 32% Potential Upside in Biotech Innovation

Bicara Therapeutics Inc. (NASDAQ: BCAX), a promising player in the biotechnology sector, is garnering attention from investors eager to explore the potential of its innovative bifunctional therapies for solid tumors...

Cogent Biosciences, Inc. (COGT): Investor Outlook on a Biotech Gem with 55% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT) stands out in the biotechnology sector, attracting investor attention with a compelling growth narrative and a promising pipeline of precision therapies. Headquartered in Waltham, Massachusetts,..

uniQure N.V. (QURE) Stock Analysis: A Potential Upside of 64% Amidst Promising Gene Therapy Innovations

For investors eyeing the healthcare sector, specifically the burgeoning field of biotechnology, uniQure N.V. (QURE) presents an intriguing opportunity. With a market capitalization of $1.52 billion, this Netherlands-based company is..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem with Over 109% Potential Upside

Savara, Inc. (NASDAQ: SVRA) is capturing attention in the healthcare sector, particularly within the biotechnology industry, due to its promising market potential. With a market capitalization of $1.06 billion, Savara..

RxSight, Inc. (RXST) Stock Analysis: Unveiling a Potential 66% Upside Amidst Market Challenges

RxSight, Inc. (NASDAQ: RXST), a pioneering player in the medical devices sector, is garnering attention from investors due to its innovative approach to cataract surgery. The company specializes in light..

CorMedix Inc. (CRMD) Stock Analysis: Uncovering an 89% Potential Upside in the Biotech Sector

Investors looking for a compelling opportunity in the healthcare sector should turn their attention to CorMedix Inc. (NASDAQ: CRMD). This biopharmaceutical company, headquartered in Parsippany, New Jersey, is primarily focused..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a 307% Potential Upside in a Promising Biotech

For investors with an eye on the biotechnology sector, LENZ Therapeutics, Inc. (NASDAQ: LENZ) presents a compelling opportunity. With a substantial market capitalization of $304.76 million, this California-based company is..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 605% Upside Potential

Investors with an eye on the biotech sector might find Anavex Life Sciences Corp. (NASDAQ: AVXL) an intriguing opportunity, especially considering its substantial potential upside of over 605%. With a..

Enliven Therapeutics, Inc. (ELVN)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `502 Bad Gateway` response: error code: 502

..

CareDx, Inc. (CDNA) Stock Analysis: Exploring 20% Upside Potential in the Transplant Diagnostics Sector

CareDx, Inc. (NASDAQ: CDNA) is a prominent player in the healthcare sector, specializing in diagnostics and research with a core focus on solutions that enhance outcomes for transplant patients. Headquartered..

SI-BONE, Inc. (SIBN) Stock Analysis: Exploring Nearly 97% Upside Potential with Strong Buy Ratings

SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector, specifically within the medical devices industry, is garnering significant attention from investors. Based in Santa Clara, California, this innovative..

Spyre Therapeutics, Inc. (SYRE): Analyst Ratings Suggest a Promising 28.77% Potential Upside

Spyre Therapeutics, Inc. (NASDAQ: SYRE) is making waves in the biotechnology sector, particularly among investors looking for high-growth potential in the healthcare arena. As a clinical-stage biotech firm, Spyre Therapeutics..

Cronos Group Inc. (CRON) Stock Analysis: Evaluating a 47% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON) is a prominent player in the healthcare sector, specializing in the cultivation and distribution of cannabis products. As individual investors consider the potential of this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds